Notes / Company

Vivanza Biosciences Ltd.

VIVANZA BSE 530057 ISIN INE984E01035 Trading

Fundamentals

Market cap: ₹8 cr
P/E: 20.30×
ROE: 0.00%
Debt / equity: 2.18
52-week range: 1.52 — 2.72

Research on Tijori Finance

Company snapshot

Vivanza Biosciences Ltd.

Miscellaneous

₹8 cr

P/E 20.30×

Latest quarter · Mar 2026

Sales₹6 cr

Net profit−₹0 cr

Op. margin−3.6%

EPS−₹0.11

Strength & growth

Debt / equity2.18×

Current ratio1.35×

Sales CAGR+47.6%

EPS CAGR−10.0%

The timeline — 1 note on Vivanza Biosciences Ltd.

June 2026

29 Jun 26 · 3:19 PM IST Brief

Brief · Micro cap

Vivanza Biosciences signs preliminary Kyrgyz deal – no money, no timeline

The nano-cap inks a non-binding MOU for plastic film in Central Asia. No financial commitment yet, but the stock may attract speculative interest.

Verify on exchange BSE filings for VIVANZA NSE filings for VIVANZA Tijori Finance company page